UW-Madison says it found a new way to fight cancer

Thanks to a recent study from the Wisconsin Institute for Discovery, UW said Chimeric Antigen Receptor T-cell therapy can be improved by altering the conditions the T-cells are grown in. Researchers at the WID accomplished this through “metabolic priming.”